Article Details
Retrieved on: 2022-12-05 21:49:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Jupiter Neuroscience (JUNS), which is developing therapies based on the nutraceutical resveratrol, has updated pricing for a proposed $15M initial ...
Article found on: seekingalpha.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here